Chimeric antigen receptor-engineered cytokine-induced killer cells overcome treatment resistance of pre-B-cell acute lymphoblastic leukemia and enhance survival-Reference-Cited by-同舟云学术

Chimeric antigen receptor-engineered cytokine-induced killer cells overcome treatment resistance of pre-B-cell acute lymphoblastic leukemia and enhance survival

Published:2016-06-11 Issue:8 Volume:139 Page:1799-1809
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Oelsner Sarah¹²,Wagner Juliane²³,Friede Miriam E.¹,Pfirrmann Verena²,Genßler Sabrina¹,Rettinger Eva²,Buchholz Christian J.⁴⁵,Pfeifer Heike⁶,Schubert Ralf⁷,Ottmann Oliver G.⁸,Ullrich Evelyn²³,Bader Peter²,Wels Winfried S.¹⁹

Affiliation:

1. Georg-Speyer-Haus; Institute for Tumor Biology and Experimental Therapy; Frankfurt Germany

2. Division for Stem Cell Transplantation and Immunology; Hospital for Children and Adolescents, Goethe University; Frankfurt Germany

3. LOEWE Center for Cell and Gene Therapy; Goethe University; Frankfurt Germany

4. Molecular Biotechnology and Gene Therapy; Paul-Ehrlich-Institut; Langen Germany

5. German Cancer Consortium (DKTK); Heidelberg Germany

6. Department of Medicine, Hematology and Oncology; Goethe University; Frankfurt Germany

7. Division for Allergology, Pneumology and Cystic Fibrosis; Hospital for Children and Adolescents, Goethe University; Frankfurt Germany

8. Department of Haematology, Division of Cancer and Genetics; Cardiff University School of Medicine; Cardiff United Kingdom

9. German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz; Germany

Funder

Deutsche Forschungsgemeinschaft

LOEWE Center for Cell and Gene Therapy Frankfurt (CGT)

Georg-Speyer-Haus, Stiftung Polytechnische Gesellschaft, Frankfurt am Main, German Federal Ministry of Health and the Ministry of Higher Education, Research and the Arts of the State of Hessen (HMWK)

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference46 articles.

1. B-acute lymphoblastic leukemia/lymphoblastic lymphoma;Loghavi;Am J Clin Pathol,2015

2. Allogeneic transplantation for pediatric acute lymphoblastic leukemia: the emerging role of peritransplantation minimal residual disease/chimerism monitoring and novel chemotherapeutic, molecular, and immune approaches aimed at preventing relapse;Pulsipher;Biol Blood Marrow Transplant,2009

3. Stem-cell transplantation in children with acute lymphoblastic leukemia: a prospective international multicenter trial comparing sibling donors with matched unrelated donors-The ALL-SCT-BFM-2003 trial;Peters;J Clin Oncol,2015

4. Graft-versus-leukemia effects of transplantation and donor lymphocytes;Kolb;Blood,2008

5. Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation;Feuchtinger;Blood,2010

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytokine-induced killer cells: new insights for therapy of hematologic malignancies;Stem Cell Research & Therapy;2024-08-13

2. CAR products from novel sources: a new avenue for the breakthrough in cancer immunotherapy;Frontiers in Immunology;2024-04-11

3. Viral therapy for targeted drug delivery to cancers: Recent advances, clinical and regulatory perspectives;Journal of Drug Delivery Science and Technology;2024-02

4. Anti-TIM3 chimeric antigen receptor-natural killer cells from engineered induced pluripotent stem cells effectively target acute myeloid leukemia cells;Cancer Cell International;2023-11-27

5. Adoptive NK Cell Therapy - a Beacon of Hope in Multiple Myeloma Treatment;Frontiers in Oncology;2023-11-03